Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label First in Human Use Pilot Study of a To-Be-Marketed Drug-Device Combination Product (sc2Wear Furosemide Combination Product) in Subjects With Chronic Heart Failure

NCT02804035 is registered in ClinicalTrials.gov with scPharmaceuticals, Inc. as lead sponsor.

NCT NCT02804035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02804035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label First in Human Use Pilot Study of a To-Be-Marketed Drug-Device Combination Product (sc2Wear Furosemide Combination Product) in Subjects With Chronic Heart Failure
Lead sponsor
scPharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2016
Completion date
August 31, 2016
Enrollment
27 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure